Interestingly, whereas low anti-PD-1 exposure in animals treated with anti-PD-1 alone allowed the tumor to grow fast (A13), a similar low exposure in the combination group (A31, 33 and 34) showed regression in tumor growth, although anti-CD96 levels were below LLOQ. The gene discussed is CD96; the disease is neoplasm.